Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
B
038460
vs
K
KOSPI 200
Over the past 12 months, BioSmart Co Ltd has underperformed KOSPI 200, delivering a return of -16% compared to KOSPI 200's +57% growth.
Stocks Performance
038460 vs KOSPI 200
Performance Gap
038460 vs KOSPI 200
Performance By Year
038460 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
BioSmart Co Ltd
Glance View
BioSmart Co Ltd makes diagnostic tests and medical devices used to check health markers from small samples such as blood or urine. Its products include in vitro diagnostic kits and related testing equipment that help doctors, labs, and clinics detect disease, monitor conditions, and support routine medical screening. The company sells these products mainly to hospitals, medical laboratories, distributors, and other healthcare customers. It makes money by selling test kits, instruments, and related consumables, so a customer often buys the equipment first and then keeps buying the disposable tests and reagents needed to run it. What makes this business different is its role in the healthcare supply chain: it sits between lab testing needs and the point of diagnosis, where speed, accuracy, and ease of use matter. That means BioSmart is not a drug maker or a hospital operator; it is a supplier of the tools and consumables that let other healthcare providers perform tests in-house.